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Tumor angiogenesisWe recently identiﬁed a novel role for the L1 transmembrane glycoprotein (also known as L1CAM or CD171) in
the regulation of tumor angiogenesis and vessels stabilization. L1 overexpression in cultured endothelial cells of
the lung (luECs) exerted a pleiotropic effect in that it regulated proliferation, migration, tubulogenesis, vascular
permeability, and endothelial-to-mesenchymal transition (EndMT). In addition, we provided strong evidence
that antibody-mediated targeting of L1 may be an effective strategy for vessel normalization with the potential
to increase efﬁcacy of chemotherapeutic agents.
High-throughput microarray expression proﬁle revealed that L1 modulates the expression of hundreds of
genes mainly involved in cell cycle regulation, DNA replication, cellular assembly, migration, development and
organization. By using a ‘pathway-oriented’ analysis strategy we were able to identify a network of 105 genes
modulated by L1 through the predicted activation of ﬁve transcription factors: STAT1, STAT2, STAT3, IRF7, and
ATF4. Indeed, L1 overexpression resulted in the strong induction of STAT3 phosphorylation which was abolished
by antibody-mediated neutralization of IL-6Rα. These results indicated that L1promoted STAT3 activation via the
IL-6/IL-6Rα axis.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
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Cell culture
Mouse luECs were immortalized with polyoma middle T antigen
and cultured in MCDB131 medium (Gibco; Life Technologies) sup-
plemented with 20% FBS (Invitrogen), 2 mM l-glutamine (Lonza),
1 mM Na-pyruvate (Gibco; Life Technologies), 100 μg/ml heparin
(Sigma-Aldrich), and 50 μg/ml EC growth supplement (ECGS)
obtained from calf brain. ECs were seeded on plates coated with
glutaraldehyde-crosslinked gelatin and cultured in complete
medium for 4 days to reach conﬂuence. A complete description of
cell culture and transfection conditions can be found in [1].RNA preparation
Total RNA was extracted from ~5 ∗ 106 cells using the RNeasy
Mini Kit (Qiagen) following manufacturer's instruction. Quality
control of the RNA samples was performed using an Agilent
Bioanalyzer 2100 (Agilent Technologies). The RNA from three inde-
pendent extractions was processed for each of the cell line under
analysis.the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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A total of 150 ng of RNA from each sample was used for RNA quality
check, labeling and hybridization on a Mouse Gene 1.0 ST Genechip
array according to the manufacturer's instructions (Affymetrix). Three
independent biological replicates were performed for each condition
(L1-transfected vs. mock-transfected luECs). Data were pre-processed
with AGCC (Affymetrix) and Expression Console 1.1. We used the
robust multi-array average (RMA) [2] to normalized data. A total of
35,512 probesets were loaded and 819,041 PM probes were used for
analysis. The library ﬁle “MoGene-1_0-st-v1.CDF” was used.
Next, we uploaded normalized data in BRB ArrayTools (http://linus.
nci.nih.gov/BRB-ArrayTools.html) to run SAM analysis (http://www-
stat.stanford.edu/~tibs/SAM/) in order to identify differentially
expressed genes upon L1 overexpression in luEC cells. The SAM param-
eters of analysis were the following:
– Number of classes: 2
– Number of probesets: 35,512
– Target proportion of false discoveries (q-value): 0.05
– Delta value used to identify signiﬁcant probesets: 1.24701
– Fudge factor for standard deviation computed: 0.04825.
Under these conditions, we identiﬁed a total of 3409 signiﬁcant
probesets corresponding to 2684 unique annotated genes (Fig. 1). We
then selected probesets having ≥1.5 fold change difference (L1 vs. ctr)
that resulted in a set of 496 upregulated and 743 downregulated
probesets annotated, corresponding to 361 upregulated and 580 down-
regulated unique genes, referred to as the ‘L1-ECs signature’. Next, we
uploaded the L1-ECs signature (probeset level) in the Ingenuity
PathwayAnalysis software (IPA, http://www.ingenuity.com) to identifyFig. 1. Signiﬁcant Analysis of Microarrays (SAM) of luECs expression proﬁle. In the y-axes,
d(i) is the observed strength of the relationship between gene expression and the
response variable (i.e. L1 overexpression). In the x-axes, dE(i) is the expected strength
(calculated by randompermutations of data) of the relationship between gene expression
and the response variable. Red dash lines represent the Δ threshold [d(i)–dE(i)] used
to call signiﬁcant genes. The Δ threshold was adjusted to allow proportion of falsely
called genes set by q-value of 0.05. In red, genes downregulated in L1-overexpressing
IuEC vs. mock-treated cells. In green, genes upregulated in L1-overexpressing IEC vs.
mock-treated cells.biological functions/pathways putatively regulated by L1. The Mouse
Gene 1.0 ST Array reference set present in the IPA database was used
for the “IPA core analysis”. Only direct relationships in mammals
(i.e., human, mouse, and rat) were considered, including endogenous
chemicals for gene network analysis. The p-values for biofunction
enrichment were corrected for multiple testing using the Benjamini-
Hochberg correction. With these settings we identiﬁed 23 bio-
functions signiﬁcantly enriched (p-value b 0.05; Benjiamini-Hochberg
correction) in L1-overexpressing cells compared to mock-transfected
cells [1]. Considering the massive changes in transcriptional activity
and the predicted effect on a variety of biological functions upon L1
overexpression, we then asked whether L1 could activate/inhibit
transcription factor(s) (TFs). To address this question, we performed
the “upstream regulator analysis” in the IPA. Such an analysis allows
the identiﬁcation of transcriptional regulators activated/inhibited
under speciﬁc experimental conditions, thus accounting for the
observed gene expression changes. Strikingly, we identiﬁed a total of
18 and 11 TFs predicted to be activated or inhibited by L1, respectively.
Of note, 5 TFs were differentially regulated in L1-overexpressing vs.
mock-transfected cells and, in particular, four of the activated TFs
were upregulated in L1 overexpressing cells (STAT1, STAT2, IRF7 and
ATF4), while one of the inhibited TFs was downregulated (FOXM1).
We then performed the Mechanistic Networks analysis to further
explore the contribution of the TFs in regulating gene networks. We
found that STAT1, STAT2, IRF7, ATF4 and STAT3 (that was among the
18 TFs predicted to be activated) interact with each other (Fig. 2), thus
exerting a coordinated control on a directional network of 105 genes
regulated by L1 (i.e. 11% of all the L1-regulated genes). Most of these
genes were consistently up- or downregulated with the expression
change of their upstream TFs [1]. These ﬁndings were supported by
functional studies which implicated the JAK/STAT signaling pathway
in the biological response of luECs to L1 overexpression [1].Fig. 2.Molecular interaction network of the upstreammodulators found by IPA. Red labels
indicate gene expression changes upon L1 overexpression (fold change). Number in
brackets indicates the number of published reports supporting the molecular interaction.
The type of interaction is also indicated (PP, protein–protein; E, expression; TR, transloca-
tion; RE, reaction; T, transcription; A, activation; I, inhibition).
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Here we describe the methods of analysis that were used to
deﬁne and characterize the gene expression proﬁle induced by L1
in murine lung endothelial cells (luECs). We used the Affymetrix
Mouse Gene 1.0 ST Arrays, which enabled us to produce gene expres-
sion data of a total of 28,869 genes (764,885 distinct probes).
Through the combined use of the Signiﬁcant Analysis of Microarrays
(SAM) and the Ingenuity Pathway Analysis (IPA), we identiﬁed a set
of 941 genes and 23 Bio-functions signiﬁcantly regulated in L1-
overexpressing vs. control luECs. We reasoned that these massive
transcriptional changes could be the result of the L1-mediated regu-
lation of TFs. Indeed, by using the “upstream modulator analysis” in
IPA we found that 29 TFs were predicted to be activated/inhibited
and, among these, 5 TFs were transcriptionally regulated in our pro-
ﬁling experiment. Among the 29 TFs identiﬁed, many are involved in
the inﬂammatory and/or angiogenic cascades (STAT1, STAT2, STAT3,
IRF1, IRF3, IRF7, RELA/p65, NFKB1 and ATF4). Of note, while L1 has
been causally linked to NF-κB signaling in cancer cells [3], we are
the ﬁrst to report a crosstalk between L1 and STATs, IRFs and ATF4.
Our data, therefore, point to L1 as a novel orchestrator of the
cancer-associated response that entails the regulation of gene net-
works and biochemical cascades which, in turn, impact on the
pathophysiology of cancer cells as well as tumor microenvironment.
Importantly, the results of our in silico analysis have been successful-
ly validated experimentally, thus lending further support to their
biological relevance.Conﬂict of interest
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